Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE